Clinical Trial Finder
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
Study Purpose
The goal of this randomized treatment study is to formally compare quality of life in patients with at least one pN0 hemi-neck after resection of a squamous cell carcinoma of the oral cavity treated with a primary radiation therapy versus a secondary targeted radiation therapy approach, to provide a high level of evidence to guide the selection of treatment options.
Recruitment Criteria
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
Inclusion Criteria:
Exclusion Criteria:
- - Unable or unwilling to complete QoL questionnaires.
- Pregnant or lactating womenTrial Details
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
The goal of this randomized treatment study is to formally compare quality of life in patients with at least one pN0 hemi-neck after resection of a squamous cell carcinoma of the oral cavity treated with a primary radiation therapy versus a secondary targeted radiation therapy approach, to provide a high level of evidence to guide the selection of treatment options. The study will require a sample size of 90 patients randomized in a 2:3 between the two arms. Arm 1 (standard radiation therapy to tumor location and surrounding area) and Arm 2 (targeted radiation therapy to tumor location). Patients will be followed for a total of 5 years.
Arms
Active Comparator: Standard Radiotherapy
Radiotherapy to all dissected areas
Experimental: Radiotherapy to smaller treatment area
Omit radiation to pN0 neck
Interventions
Radiation: - Radiotherapy to all dissected areas
Post operative radiation therapy +/- chemotherapy based on historic treatment volumes (including the primary site, dissected areas +/- elective areas
Radiation: - Omit radiation to pN0 neck
post operation radiation therapy +/- chemotherapy that avoids targeting the dissected pN0 neck
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Recruiting
Address
Miami Cancer Institute
Miami, Florida, 33143
Site Contact
Noah Kalman, MD
[email protected]
786-596-2000
International Sites
Status
Recruiting
Address
London Regional Cancer Program
London, Ontario, N6A 5W9
Site Contact
Pencilla Lang, MD
[email protected]
519-685-8500
Status
Recruiting
Address
CHUM
Montréal, Quebec, H2X 0A9
Site Contact
Houda Bahig, MD
[email protected]
5148908000
Status
Recruiting
Address
Cork University Hospital
Wilton, County Cork,
Site Contact
Kathy Rock, MD
[email protected]
1 353 86 8420854
Status
Recruiting
Address
University Hospital Galway, Newcastle Road
Galway, County Galway, H91 T861
Site Contact
Emma Stone
[email protected]
+353 91 54 8709
Status
Recruiting
Address
St. Luke's Radiation Oncology Network
Rathgar, Dublin,
Site Contact
Sinead Brennan, MD
[email protected]
353 1 406 5000
Status
Recruiting
Address
Beaumont St. Luke's Centre
Dublin, Leinster, D09FT51
Site Contact
Sinead Brennan
[email protected]
353 1 406 5000
Status
Recruiting
Address
Beatson West of Scotland Cancer Centre
Glasgow, , G12 OYN
Site Contact
Claire Paterson, MD
[email protected]
0141 301 7066
Privacy Overview